belactosin A

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2013
01220032013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
We previously developed highly potent proteasome inhibitor 1 (IC50 = 5.7 nM) and its nonpeptide derivative 2 (IC50 = 29 nM) by… (More)
Is this relevant?
2013
2013
The natural product belactosin A (1) with a trans-cyclopropane structure is a useful prototype compound for developing potent… (More)
Is this relevant?
2009
2009
The development of potent proteasome inhibitors based on the stereochemical diversity-oriented strategy using a conformationally… (More)
Is this relevant?
2009
2009
The proteasome inhibitors are used as research tools to study of the ATP-dependent ubiquitin-proteasome system. Some of them are… (More)
  • figure 1
  • table I
  • table II
  • table III
  • table IV
Is this relevant?
2008
2008
Belactosin A is a potent proteasome inhibitor isolated from Streptomyces metabolites. Here we show that a hydrophobic belactosin… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2008
2008
A series of chiral 2,3- and 3,4-methanoamino acid equivalents of stereochemical diversity were designed and synthesized from our… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
2004
2004
[reaction: see text] Enantioselective total syntheses of belactosin A, belactosin C, and its homoanalogue have been accomplished… (More)
Is this relevant?
2004
2004
A concise first total synthesis of the antitumour antibiotic belactosin A is reported, involving coupling of beta-lactone… (More)
Is this relevant?
2004
2004
A yeast-based growth interference assay was developed utilizing a yeast strain in which expression of Xenopus cyclin A1 was… (More)
Is this relevant?
2003
2003
Herein we report a concise synthesis of 3-(trans-2-aminocyclopropyl)alanine, a component of belactosin A, using asymmetric… (More)
Is this relevant?